Phase I Trial of Measles Vectored Chikungungya Vaccine

NCT03028441 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

180

Enrollment

NIH

Sponsor class

Conditions

Chikungunya Virus Infection

Interventions

OTHER: Placebo
BIOLOGICAL: VRC-CHKVLP059-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)